163 related articles for article (PubMed ID: 37143539)
1. Traditional mineral medicine realgar and
Luo L; Li C; Huang N; Wang Q; Zhang Z; Song C; Yang H; Yuan M; Xu Z; Sun J; Zhang Z
Front Microbiol; 2023; 14():1143173. PubMed ID: 37143539
[TBL] [Abstract][Full Text] [Related]
2. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology.
Jiang Z; Sun Y; Wu Z; Tang M; Ye A; Tu B; Yi J; Xu H; Gao Y
J Ethnopharmacol; 2023 Dec; 317():116895. PubMed ID: 37467822
[TBL] [Abstract][Full Text] [Related]
3. Influences of Realgar-
Xu HH; Hao FR; Wang MX; Ren SJ; Li M; Tan HL; Wang YG; Tang XL; Xiao CR; Liang QD; Gao Y; Ma ZC
Evid Based Complement Alternat Med; 2017; 2017():2374624. PubMed ID: 28421119
[TBL] [Abstract][Full Text] [Related]
4. Research on different compound combinations of Realgar-Indigo naturalis formula to reverse acute promyelocytic leukemia arsenic resistance by regulating autophagy through mTOR pathway.
Li R; Xue C; Pan Y; Li G; Huang Z; Xu J; Zhang J; Chen X; Hou L
J Ethnopharmacol; 2024 May; 326():117778. PubMed ID: 38310990
[TBL] [Abstract][Full Text] [Related]
5. A novel realgar-indigo naturalis formula more effectively induces apoptosis in NB4 cells.
Xie Q; Yu L; Wang X; Wu Z; Zhi D; Yang J; Guo Z; Wu T; Sun Y; Zhao L; Ding X; Khan A; Li H
Pak J Pharm Sci; 2019 May; 32(3):957-962. PubMed ID: 31278706
[TBL] [Abstract][Full Text] [Related]
6. Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia.
Lou Y; Ma Y; Jin J; Zhu H
Front Oncol; 2020; 10():597601. PubMed ID: 33614484
[TBL] [Abstract][Full Text] [Related]
7. [Effect of clinical doses of Realgar-Indigo Naturalis formula and large-dose of realgar on CYP450s of rat liver].
Xu HH; Wang MX; Tan HL; Wang YG; Tang XL; Xiao CR; Li H; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):593-599. PubMed ID: 28952270
[TBL] [Abstract][Full Text] [Related]
8. Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial.
Zhang X; Liu L; Yao Y; Gong S; Wang M; Xi J; Chen L; Wei S; Zhang H; Zhao C; Wang H
Trials; 2020 Jan; 21(1):7. PubMed ID: 31898521
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
[TBL] [Abstract][Full Text] [Related]
10. The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia.
Liao LH; Chen YQ; Huang DP; Wang LN; Ye ZL; Yang LH; Mai HR; Li Y; Liang C; Luo JS; Wang LN; Luo XQ; Tang YL; Zhang XL; Huang LB
Cancer Chemother Pharmacol; 2022 Jul; 90(1):45-52. PubMed ID: 35760920
[TBL] [Abstract][Full Text] [Related]
11. Absorption Characteristics of Combination Medication of Realgar and
Zhang M; Guo L; Lin LF; Qu CH; Yin XB; Luo SL; Zhang X; Zhang HY; Liang X; Guan J; Ni J
Evid Based Complement Alternat Med; 2018; 2018():6493630. PubMed ID: 30258467
[TBL] [Abstract][Full Text] [Related]
12. Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota.
Sun Z; Li J; Dai Y; Wang W; Shi R; Wang Z; Ding P; Lu Q; Jiang H; Pei W; Zhao X; Guo Y; Liu J; Tan X; Mao T
Front Microbiol; 2020; 11():731. PubMed ID: 32425906
[TBL] [Abstract][Full Text] [Related]
13. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study.
Yang MH; Wan WQ; Luo JS; Zheng MC; Huang K; Yang LH; Mai HR; Li J; Chen HQ; Sun XF; Liu RY; Chen GH; Feng X; Ke ZY; Li B; Tang YL; Huang LB; Luo XQ
Am J Hematol; 2018 Dec; 93(12):1467-1473. PubMed ID: 30160789
[TBL] [Abstract][Full Text] [Related]
14. Arsenic Bioaccessibility of Realgar Influenced by the Other Traditional Chinese Medicines in Niuhuang Jiedu Tablet and the Roles of Gut Microbiota.
Xu W; Xu S; Zhang S; Wu X; Jin P
Evid Based Complement Alternat Med; 2019; 2019():8496817. PubMed ID: 31929821
[TBL] [Abstract][Full Text] [Related]
15. Arsenic Accumulation of Realgar Altered by Disruption of Gut Microbiota in Mice.
Xu W; Zhang S; Jiang W; Xu S; Jin P
Evid Based Complement Alternat Med; 2020; 2020():8380473. PubMed ID: 32908570
[TBL] [Abstract][Full Text] [Related]
16. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia.
Wang L; Zhou GB; Liu P; Song JH; Liang Y; Yan XJ; Xu F; Wang BS; Mao JH; Shen ZX; Chen SJ; Chen Z
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4826-31. PubMed ID: 18344322
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study of Realgar and arsenic trioxide on gut microbiota of mice].
Sun YT; Xu HH; Nie Y; Wang YG; Ma ZC; Zhou W; Tan HL; Gao Y
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):142-148. PubMed ID: 32237423
[TBL] [Abstract][Full Text] [Related]
18. Clinical study on prospective efficacy of all-trans Acid, realgar-indigo naturalis formula combined with chemotherapy as maintenance treatment of acute promyelocytic leukemia.
Xiang-Xin L; Lu-Qun W; Hao L; Xiao-Peng H; Fang-Lin L; Ling-Ling W; Xue-Liang C; Ming H
Evid Based Complement Alternat Med; 2014; 2014():987560. PubMed ID: 24963332
[TBL] [Abstract][Full Text] [Related]
19. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of early switching to an outpatient therapy model using oral arsenic plus retinoic acid based-regimen in newly diagnosed acute promyelocytic leukemia.
Lou Y; Tong H; Yu W; Wei J; Xu W; Mao L; Jin J
Leuk Res; 2019 Aug; 83():106168. PubMed ID: 31202077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
